Retinol

ApprovedSmall molecule

SStanford University

Retinol is one of 7 small molecule programs targeting Skin Aging. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Skin AgingActive, not recruiting

Skin AgingApproved

Active, not recruiting

Competition

Competitive Landscape

12 competitors in Skin Aging

#DrugCompanyPhaseTrials

Botox

VVitae Pharmaceuticals Inc., an Allergan affiliate

Phase 3

—2

Dehydroepiandrosterone

IInflabloc Pharmaceuticals

Phase 3

1 3

Retinol

SStanford University

Approved

1 4

Platelet Rich Plasma

ZZagazig University

Phase 2

1 5

Sulforaphane

EEastern Cooperative Oncology Group

Phase 1

2 6

Botox

RRevance Therapeutics, Inc.

Preclinical

—7

Retin-a

VValeant Pharmaceuticals

Preclinical

—

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

MPA1 trial

Comparison of the Cosmetic Effects of Bakuchiol and Retinol

Completed·UUniversity of California, Davis·Phase 1·NCT03112863·44 enrolled

Skin Aging1 trial

Retinol on Human Skin Aging in East Asian Descent

Completed·SStanford University·Phase 4·NCT02906566·110 enrolled

Treatment1 trial

Comparison of Retinol 1.0% and Tretinoin 0.02% in the Treatment of Moderate to Severe Photodamage and Wrinkles

Completed·JJohns Hopkins University·Phase 2·NCT01283464·24 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for Retinol. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Retinol compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Retinol. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Stanford University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: SStanford University

Retinol

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

MPA1 trial

Skin Aging1 trial

Treatment1 trial

References

Drug Info

Quick Facts

Related News